Cephalexin
Product Images NDC 70934-108

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 70934-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 108 40 Rev A 05 18)

Label (70934 108 40   Rev A 05 18)
Cephalexin Capsules, USP 250mg, in a package of 40 capsules by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label includes storage instructions, dosage reference to the package insert, and a note that the capsules are Rx only and controlled room temperature stable. The packaging also shows lot number, expiration date, and barcode information.*
FDA Label Image

Cephalexin-str (Cephalexin Str)

Cephalexin-str (Cephalexin Str)
Chemical structure of Cephalexin showing its molecular framework including a beta-lactam ring, thiazolidine ring, and associated functional groups, along with a water molecule (hydrate form).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.